國家衛生研究院 NHRI:Item 3990099045/11788
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 909841      在线人数 : 859
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    主页登入上传说明关于NHRI管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/11788


    题名: Histone demethylase KDM4C is a novel oncogene and prognostic biomarker for prostate cancer
    作者: Chuu, CP;Lin, CY;Wang, BJ;Chen, BC;Tseng, JC
    贡献者: Institute of Cellular and Systems Medicine
    摘要: Background: Prostate cancer (PCa) is the 5th most common cancer overall in the world. Epigenetic alterations is involved in the development or progression of cancer via regulation of histone modifications. Histone lysine demethylases KDM4C is androgen receptor (AR) co-regulator and modulate AR-mediated transcription. Expression of KDM4C was reported to be higher in castration-resistant prostate cancer (CRPC). Methods: Role of KDM4C in cell proliferation and docetaxel-resistance was determined using MTT assay and 96-well proliferation assay. Effects of KDM4C on PCa migration and invasion was determined by trasnwell assay. Role of KDM4C on cancer stemness was examined using cell sorter. Inhibitory role...
    日期: 2018-10
    關聯: Annals of Oncology. 2018 Oct;29(Suppl. 7):Meeting Abstract O1-19-2.
    Link to: https://doi.org/10.1093/annonc/mdy374.016
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0923-7534&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000459058600058
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85081687045
    显示于类别:[褚志斌] 會議論文/會議摘要

    文件中的档案:

    没有与此文件相关的档案.



    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈